To evaluate the effect of adenotonsillectomy (T&A) in obese children with obstructive sleep apnea (OSA) and to compare changes in high-sensitivity C-reactive protein (hs-CRP) levels before and 6 months after T&A in obese children with OSA.
Study Design
Before and after study with planned data collection.
Setting
Tertiary care, university-based pediatric hospital.
Subjects and Methods
Seventy-five obese children with OSA were included. Clinical information such as the apnea-hypopnea index (AHI), nadir oxyhemoglobin saturation (SaO2), and body mass index (BMI) were recorded. The hs-CRP level was determined before T&A and at the 6-month follow-up examination.
Results
Reductions in AHI (21.96 ± 9.277 before T&A vs 8.64 ± 5.997 after 6 months of T&A) and higher levels of nadir SaO2 (74.08 ± 7.860 before T&A vs 86.87 ± 5.586 after 6 months of T&A) were observed. The hs-CRP levels were obviously correlated with BMI (r = 0.7948, P < .001). Other than AHI (r = 0.0579, P = .6217) in obese children, however, hs-CRP levels showed no changes 6 months after T&A therapy.
Conclusion
T&A treatment improves clinical signs and symptoms in obese children but does not reduce chronic inflammation as reflected by hs-CRP. To lower the risks of cardiovascular disease and diabetes mellitus morbidity, other treatments should be taken into account.
DrummondMWinckJGuimarãesJ. Long term effect of autoadjusting positive airway pressure on C-reactive protein and interleukin-6 in men with obstructive sleep apnoea syndrome. Arch Bronconeumol. 2009;45:577-584.
2.
ShamsuzzamanASWinnickiMLanfranchiP. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 2002;105:2462-2464.
3.
VgontzasANPapanicolaouDABixlerEO. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab. 1997;82:1313-1316.
4.
KaditisAGFinderJAlexopoulosEI. Sleep-disordered breathing in 3,680 Greek children. Pediatr Pulmonol. 2004;37:499-509.
5.
XuZJiaqingAYuchuanL. A case-control study of obstructive sleep apnea-hypopnea syndrome in obese and nonobese chinese children. Chest. 2008;133:684-689.
6.
WingYHuiSPakW. A controlled study of sleep related disordered breathing in obese children. Arch Dis Child. 2003;88:1043-1047.
7.
MarcusCKatzELutzJ. Upper airway dynamic responses in children with the obstructive sleep apnea syndrome. Pediatric Research. 2005;57:99-107.
8.
SuenJArnoldJBrooksL. Adenotonsillectomy for treatment of obstructive sleep apnea in children. Arch Otolaryngol Head Neck Surg. 1995;121:525-530.
9.
TaumanRGulliverTEKrishnaJ. Persistence of obstructive sleep apnea syndrome in children after adenotonsillectomy. J Pediatr. 2006;149:803-808.
10.
PasceriVWillersonJTYehET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102:2165-2168.
11.
PfütznerASchöndorfTHanefeldM. High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone. J Diabetes Sci Technol. 2010;4:706-716.
12.
CaoJJAmoldAMManolioTA. Association of carotidartery intima-media thickness, plaques and C-reactive protein with future cardiovascular disease and all cause mortality: the Cardiovascular Health Study. Circulation. 2007;116:32-38.
13.
ShankarALiJ. Positive association between high-sensitivity C-reactive protein level and diabetes mellitus among US non-Hispanic black adults. Exp Clin Endocrinol Diabetes. 2008;116:455-460.
14.
LarkinEKRosenCLKirchnerHL. Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration. Circulation. 2005;111:1978-1984.
15.
LiAMChanMHYinJ. C-reactive protein in children with obstructive sleep apnea and the effects of treatment. Pediatr Pulmonol. 2008;43:34-40.
16.
Group of China Obesity Task Force. Body mass index reference norm for screening overweight and obesity in Chinese children and adolescents [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 2004;25:97-102.
17.
Sleep-related breathing disorders in adults: recommendations syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep. 1999;22:667-689.
18.
KudohFSanaiA. Effect of tonsillectomy and adenoidectomy on obese children with sleep- associated breathing disorders. Acta Otolayngol. 1996;523:216-218.
19.
MitchellRBKellyJ. Outcome of adenotonsillectomy for obstructive sleep apnea in obese and normal-weight children. Otolaryngol Head Neck Surg. 2007;137:43-48.
20.
O’BrienLMSithaSBaurLA. Obesity increases the risk for persisting obstructive sleep apnea after treatment in children. Int J Pediatr Otorhinolaryngol. 2006;70:1555-1560.
21.
CostaDJMitchellR. Adenotonsillectomy for obstructive sleep apnea in obese children: a meta-analysis. Otolaryngol Head Neck Surg. 2009;140:455-460.
22.
TaumanRIvanenkoAO’BrienLM. Plasma C-reactive protein levels among children with sleep-disordered breathing. Pediatrics. 2004;113:e564-e569.
23.
ChenJDuoLK. Changes of high-sensitivity CRP and insulin sensitivity index in children with obstructive sleep apnea hypopnea syndrome. Zhongguo Dang Dai Er Ke Za Zhi. 2011;13:208-211.
24.
ValleMMartosRGascónF. Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab. 2005;31:55-62.
25.
CaiGColeSAButteNF. A genetic contribution to circulating cytokines and obesity in children. Cytokine. 2008;44:242-247.
26.
SchwarzenbergSJSinaikoAR. Obesity and inflammation in children. Paediat Respir Rev. 2006;7:239-246.
27.
VincentHKTaylorAG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes. 2006;30:400-418.
28.
HicklingSHungJKnuimanM. Are the associations between diet and C-reactive protein independent of obesity?Prev Med. 2008;47:71-76.
29.
GallandL. Diet and inflammation. Nutr Clin Pract. 2010;25:634-640.
30.
RidkerPM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363-369.
31.
PaffenEdeMaatMP. C-reactive protein in atherosclerosis: a causal factor?Cardiovasc Res. 2006;71:30-39.
32.
ShankarALiJ. Positive association between high-sensitivity C-reactive protein level and diabetes mellitus among US non-Hispanic black adults. Exp Clin Endocrinol Diabetes. 2008;116:455-460.
33.
DevarajSSinghUJialalI. Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol. 2009;20:182-189.
34.
NishinaMKikuchiTYamazakiH. Relationship among systolic blood pressure, serum insulin and leptin, and visceral fat accumulation in obese children. Hypertens Res. 2003;26:281-288.
35.
CsabiGTorokKJegesS. Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr. 2000;159:91-94.
36.
BaysHEChapmanRHGrandyS. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract. 2007;61:737-747.
